MiMedx Concludes Enrollment for Phase III Plantar Fasciitis Trial

MiMedx completed enrollment for a Phase III study of plantar fasciitis. This clinical trial is exploring ways that placental science may address and treat musculoskeletal pain and function disorders. It is designed to provide statistically significant evidence of efficacy for such a biologic treatment to reduce pain and improve function.


document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us